Trial intelligence / Profile preview

Omeprazole versus placebo with platinum chemotherapy: magnesium levels and neurologic toxicity

RBR-8vsb7k2Phase 4Completed

Sponsor
Universidade Federal do Rio Grande do Norte
Start
May 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in cancer comparing Omeprazole add-on with Placebo control (2 arms). Primary endpoints: Change in intraerythrocyte magnesium concentration and Change in serum magnesium concentration. Started May 2019; status: completed.

02

Drugs

omeprazole
03

Conditions

cancer

Beyond the preview

Go deeper on RBR-8vsb7k2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-8vsb7k2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call